10x Genomics Inc. (TXG) Quarterly Performance is 17.33%: Here is the Surprise Factor

Let’s start up with the current stock price of 10x Genomics Inc. (TXG), which is $96.81 to be very precise. The Stock rose vividly during the last session to $98.28 after opening rate of $96.69 while the lowest price it went was recorded $94.49 before closing at $96.90.

Recently in News on August 11, 2020, 10x Genomics Reports Second Quarter 2020 Financial Results. 10x Genomics, Inc. (Nasdaq: TXG) today reported financial results for the second quarter ended June 30, 2020. You can read further details here

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, 10x Genomics Inc. shares are logging -10.66% during the 52-week period from high price, and 114.61% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $45.11 and $108.36.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 856565 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the 10x Genomics Inc. (TXG) recorded performance in the market was 27.08%, having the revenues showcasing 17.33% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 9.84B, as it employees total of 584 workers.

Analysts verdict on 10x Genomics Inc. (TXG)

During the last month, 5 analysts gave the 10x Genomics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 81.46, with a change in the price was noted +42.71. In a similar fashion, 10x Genomics Inc. posted a movement of +76.57% for the period of last 100 days, recording 752,798 in trading volumes.

Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for TXG is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.

10x Genomics Inc. (TXG): Technical Analysis

Raw Stochastic average of 10x Genomics Inc. in the period of last 50 days is set at 87.05%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 78.34%. In the last 20 days, the company’s Stochastic %K was 72.02% and its Stochastic %D was recorded 71.41%.

Let’s take a glance in the erstwhile performances of 10x Genomics Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 27.08%. The shares increased approximately by -2.15% in the 7-day charts and went down by 10.82% in the period of the last 30 days. Common stock shares were driven by 17.33% during last recorded quarter.